Concepedia
Statistics
Publications
60
Citations
7K
H-Index
36
Active since
1989
Affiliations
Inserm(Current)
Université de Strasbourg
Hôpitaux Universitaires de Strasbourg
Hôpital Beaujon
Hôpital Civil, Strasbourg
François Habersetzer is an author at Inserm specializing in viral hepatitis, infectious diseases, and antiviral therapy.
Publications per year
1989–2023
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations
Medicine, Oncology, Radiation Oncology +16
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat, Hélène Fontaine, Céline Dorival et al. · The Lancet · 2019 · 631 citations · Full text
Pharmacy, Pharmacotherapy, Outcomes Research +13
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells
Vedashree Ramakrishnaiah, Christine Thumann, Isabel Fofana et al. · Proceedings of the National Academy of Sciences · 2013 · 495 citations · Full text
Life Sciences, Infectious Diseases, Microbiology +17
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
1–5 of 60